Value-based medicine and ophthalmology: An appraisal of costutility analyses

Gary C. Brown; Melissa M. Brown; Sanjay Sharma; Heidi Brown; Lindsay Smithen; David B. Leeser; George Beauchamp; Charles P. Wilkinson; W. Banks Anderson; George L. Spaeth; David L. Guyton; Rick Ferris; Carol L. Shields

Value-based medicine and ophthalmology: An appraisal of costutility analyses

Gary C. Brown, Melissa M. Brown, Sanjay Sharma, Heidi Brown, Lindsay Smithen, David B. Leeser, George Beauchamp, Charles P. Wilkinson, W. Banks Anderson, George L. Spaeth, David L. Guyton, Rick Ferris, Carol L. Shields

School of Medicine

Research output: Contribution to journal › Review article › peer-review

23 Scopus citations

Abstract

Purpose: To ascertain the extent to which ophthalmologic interventions have been evaluated in value-based medicine format. Methods: Retrospective literature review. Papers in the healthcare literature utilizing cost-utility analysis were reviewed by researchers at the Center for Value-Based Medicine, Flourtown, Pennsylvania. A literature review of papers addressing the cost-utility analysis of ophthalmologic procedures in the United States over a 12-year period from 1992 to 2003 was undertaken using the National Library of Medicine and EMBASE databases. The cost-utility of ophthalmologic interventions in inflation-adjusted (real) year 2003 US dollars expended per quality-adjusted life-year ($/QALY) was ascertained in all instances. Results: A total of 19 papers were found, including a total of 25 interventions. The median cost-utility of ophthalmologic interventions was $5,219/QALY, with a range from $746/QALY to $6.5 million/QALY. Conclusions: The majority of ophthalmologic interventions are especially cost-effective by conventional standards. This is because of the substantial value that ophthalmologic interventions confer to patients with eye diseases for the resources expended.

Original language	English (US)
Pages (from-to)	177-188
Number of pages	12
Journal	Transactions of the American Ophthalmological Society
Volume	102
State	Published - 2004

ASJC Scopus subject areas

Ophthalmology

Cite this

@article{d5e2bfaeca074a8299c0e930f9ab61a9,

title = "Value-based medicine and ophthalmology: An appraisal of costutility analyses",

abstract = "Purpose: To ascertain the extent to which ophthalmologic interventions have been evaluated in value-based medicine format. Methods: Retrospective literature review. Papers in the healthcare literature utilizing cost-utility analysis were reviewed by researchers at the Center for Value-Based Medicine, Flourtown, Pennsylvania. A literature review of papers addressing the cost-utility analysis of ophthalmologic procedures in the United States over a 12-year period from 1992 to 2003 was undertaken using the National Library of Medicine and EMBASE databases. The cost-utility of ophthalmologic interventions in inflation-adjusted (real) year 2003 US dollars expended per quality-adjusted life-year ($/QALY) was ascertained in all instances. Results: A total of 19 papers were found, including a total of 25 interventions. The median cost-utility of ophthalmologic interventions was $5,219/QALY, with a range from $746/QALY to $6.5 million/QALY. Conclusions: The majority of ophthalmologic interventions are especially cost-effective by conventional standards. This is because of the substantial value that ophthalmologic interventions confer to patients with eye diseases for the resources expended.",

author = "Brown, {Gary C.} and Brown, {Melissa M.} and Sanjay Sharma and Heidi Brown and Lindsay Smithen and Leeser, {David B.} and George Beauchamp and Wilkinson, {Charles P.} and Anderson, {W. Banks} and Spaeth, {George L.} and Guyton, {David L.} and Rick Ferris and Shields, {Carol L.}",

year = "2004",

language = "English (US)",

volume = "102",

pages = "177--188",

journal = "Transactions of the American Ophthalmological Society",

issn = "1545-6110",

publisher = "American Ophthalmological Society",

}

TY - JOUR

T1 - Value-based medicine and ophthalmology

T2 - An appraisal of costutility analyses

AU - Brown, Gary C.

AU - Brown, Melissa M.

AU - Sharma, Sanjay

AU - Brown, Heidi

AU - Smithen, Lindsay

AU - Leeser, David B.

AU - Beauchamp, George

AU - Wilkinson, Charles P.

AU - Anderson, W. Banks

AU - Spaeth, George L.

AU - Guyton, David L.

AU - Ferris, Rick

AU - Shields, Carol L.

PY - 2004

Y1 - 2004

N2 - Purpose: To ascertain the extent to which ophthalmologic interventions have been evaluated in value-based medicine format. Methods: Retrospective literature review. Papers in the healthcare literature utilizing cost-utility analysis were reviewed by researchers at the Center for Value-Based Medicine, Flourtown, Pennsylvania. A literature review of papers addressing the cost-utility analysis of ophthalmologic procedures in the United States over a 12-year period from 1992 to 2003 was undertaken using the National Library of Medicine and EMBASE databases. The cost-utility of ophthalmologic interventions in inflation-adjusted (real) year 2003 US dollars expended per quality-adjusted life-year ($/QALY) was ascertained in all instances. Results: A total of 19 papers were found, including a total of 25 interventions. The median cost-utility of ophthalmologic interventions was $5,219/QALY, with a range from $746/QALY to $6.5 million/QALY. Conclusions: The majority of ophthalmologic interventions are especially cost-effective by conventional standards. This is because of the substantial value that ophthalmologic interventions confer to patients with eye diseases for the resources expended.

AB - Purpose: To ascertain the extent to which ophthalmologic interventions have been evaluated in value-based medicine format. Methods: Retrospective literature review. Papers in the healthcare literature utilizing cost-utility analysis were reviewed by researchers at the Center for Value-Based Medicine, Flourtown, Pennsylvania. A literature review of papers addressing the cost-utility analysis of ophthalmologic procedures in the United States over a 12-year period from 1992 to 2003 was undertaken using the National Library of Medicine and EMBASE databases. The cost-utility of ophthalmologic interventions in inflation-adjusted (real) year 2003 US dollars expended per quality-adjusted life-year ($/QALY) was ascertained in all instances. Results: A total of 19 papers were found, including a total of 25 interventions. The median cost-utility of ophthalmologic interventions was $5,219/QALY, with a range from $746/QALY to $6.5 million/QALY. Conclusions: The majority of ophthalmologic interventions are especially cost-effective by conventional standards. This is because of the substantial value that ophthalmologic interventions confer to patients with eye diseases for the resources expended.

UR - http://www.scopus.com/inward/record.url?scp=17244376248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17244376248&partnerID=8YFLogxK

M3 - Review article

C2 - 15747756

AN - SCOPUS:17244376248

SN - 1545-6110

VL - 102

SP - 177

EP - 188

JO - Transactions of the American Ophthalmological Society

JF - Transactions of the American Ophthalmological Society

ER -

Value-based medicine and ophthalmology: An appraisal of costutility analyses

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this